GoodRx and GEO Group Top Expectations, Outlook Miss
- August 09th, 2023
- 370 views
GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projected revenue of $186.82 million. However, GoodRx anticipates Q3 revenue to range between approximately $186 million and $190 million, contrasting with the consensus estimate of $192.58 million for the period.
$GDRX was trading at $8.65 in pre-market, reflecting a decrease of $0.09 (-1.03%).
Shifting focus, The GEO Group, Inc. (NYSE: GEO) reported earnings of $0.24 per share for Q2 2023, surpassing the consensus EPS estimate of $0.20. The company's quarterly revenues reached $593.90 million, exceeding the analysts' expected revenue of $588.26 million. GEO Group projects full-year 2023 revenues around $2.4 billion, slightly below the consensus estimate of $2.43 billion for the period.
In pre-market, $GEO was trading at $7.02, down $0.26 (-3.57%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login